Skip to main content

Research Repository

Advanced Search

Multicentre service evaluation of presentation of newly diagnosed cancers and type 1 diabetes in children in the UK during the COVID-19 pandemic

Williams, Gemma; McLean, Ross; Liu, Jo Fen; Ritzmann, Timothy A; Dandapani, Madhumita; Shanmugavadivel, Dhurgshaarna; Sachdev, Pooja; Brougham, Mark; Mitchell, Rod T; Conway, Nicholas T; Law, James; Cunnington, Alice; Ogunnaike, Gbemi; Brougham, Karen; Bayman, Elizabeth; Walker, David

Multicentre service evaluation of presentation of newly diagnosed cancers and type 1 diabetes in children in the UK during the COVID-19 pandemic Thumbnail


Authors

Gemma Williams

Ross McLean

Jo Fen Liu

Profile image of MADHUMITA DANDAPANI

Dr MADHUMITA DANDAPANI Madhumita.Dandapani@nottingham.ac.uk
Clinical Associate Professor of Paediatric Oncology/Neuro Oncology

Pooja Sachdev

Mark Brougham

Rod T Mitchell

Nicholas T Conway

James Law

Alice Cunnington

Gbemi Ogunnaike

Karen Brougham

Elizabeth Bayman

David Walker



Abstract

Background The COVID-19 pandemic led to changes in patterns of presentation to emergency departments. Child health professionals were concerned that this could contribute to the delayed diagnosis of life-threatening conditions, including childhood cancer (CC) and type 1 diabetes (T1DM). Our multicentre, UK-based service evaluation assessed diagnostic intervals and disease severity for these conditions. Methods We collected presentation route, timing and disease severity for children with newly diagnosed CC in three principal treatment centres and T1DM in four centres between 1 January and 31 July 2020 and the corresponding period in 2019. Total diagnostic interval (TDI), patient interval (PI), system interval (SI) and disease severity across different time periods were compared. Results For CCs and T1DM, the route to diagnosis and severity of illness at presentation were unchanged across all time periods. Diagnostic intervals for CCs during lockdown were comparable to that in 2019 (TDI 4.6, PI 1.1 and SI 2.1 weeks), except for an increased PI in January-March 2020 (median 2.7 weeks). Diagnostic intervals for T1DM during lockdown were similar to that in 2019 (TDI 16 vs 15 and PI 14 vs 14 days), except for an increased PI in January-March 2020 (median 21 days). Conclusions There is no evidence of diagnostic delay or increased illness severity for CC or T1DM, during the first phase of the pandemic across the participating centres. This provides reassuring data for children and families with these life-changing conditions.

Citation

Williams, G., McLean, R., Liu, J. F., Ritzmann, T. A., Dandapani, M., Shanmugavadivel, D., …Walker, D. (2021). Multicentre service evaluation of presentation of newly diagnosed cancers and type 1 diabetes in children in the UK during the COVID-19 pandemic. BMJ Paediatrics Open, 5(1), Article e001078. https://doi.org/10.1136/bmjpo-2021-001078

Journal Article Type Article
Acceptance Date Aug 3, 2021
Online Publication Date Nov 11, 2021
Publication Date Nov 11, 2021
Deposit Date Dec 2, 2021
Publicly Available Date Dec 7, 2021
Journal BMJ Paediatrics Open
Electronic ISSN 2399-9772
Publisher BMJ Publishing Group
Peer Reviewed Peer Reviewed
Volume 5
Issue 1
Article Number e001078
DOI https://doi.org/10.1136/bmjpo-2021-001078
Keywords Pediatrics, Perinatology, and Child Health, COVID-19
Public URL https://nottingham-repository.worktribe.com/output/6845226
Publisher URL https://bmjpaedsopen.bmj.com/content/5/1/e001078

Files





You might also like



Downloadable Citations